Targeting cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma – Sheila Singh from McMaster University, Canada, presented her research on MYC-driven medulloblastoma (MB), an aggressive pediatric brain tumor characterized by therapy resistance and disease recurrence. Here, MYC is linked to brain neoplasm.